Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // July 22nd, 2011 // 7:04 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Rabin Martin consulting is adding Jeff Sturchio as a senior partner to guide strategy, identify emerging issues and create partnerships for corporate, multilateral and nonprofit clients. Sturchio is currrently ceo of the Global Health Council, an alliance of public health organizations and professionals. Previously, he spent nearly 20 years at Merck, where he was vp of corporate responsibility and president of The Merck Company Foundation.
Sanofi shifted US prez Greg Irace to sr vp of global services;
Aegerion Pharmaceuticals added Paul Thomas to its board;
MSI Consultancy named Jon Bircher as managing director;
Elorad promoted Christopher Gabanski to chief commercial officer;
ACR Image Metrix hired Kathy Freeman as business development manager;
Advaxis hired Ashok Amin as vp of R&D;
Agennix hired Christine Boisclair as senior vp of global regulatory affairs;
Synteract hired Wendel Barr as ceo;
PharmaNet Development named George Scott as vp bioanalytical services;
Phadia hired Dennis Flannelly as head of US marketing and strategy;
Portola Pharmaceuticals named Michael Kitt as chief medical officer;
Intellikine hired Greg Berk as chief medical officer;
Yaupon Therapeutics named Tim Henkel exec vp of R&D;
Yaupon Therapeutics named Doug Gessl as coo and cfo;
Yaupon Therapeutics named H. Jeffrey Wilkins as chief medical officer;
Stem Cell Therapeutics added Calvin Stiller and Niclas Stiernholm to its board;
Jefferies hired Dung Nguyen as managing director in healthcare investment banking;
BioSante Pharma named Patricia Adams as vp, human resources;
BioSante Pharma named Sandra Croak-Brossman as vp, regulatory affairs and quality assurance;
Ladder shot thx to Robert CB on Flickr Creative Commons
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
ACR Image Metrix, Advaxis, Aegerion Pharmaceuticals, Agennix, BioSante Pharmaceuticals, Elorad, Intellikine, Jefferies, Merck, MSI Consultancy, Phadia, PharaNet Development Group, Portola Pharmaceuticals, Rabin Martin, Sanofi, Stem Cell Therapeutics, Synteract, Yaupon Therapeutics